Expert Interview
Discussing high-level positive results from AstraZeneca’s Breztri as it meets primary endpoints in KALOS and LOGOS Phase III trials in asthma
Ticker(s): AZNInstitution: University of South Florida
- Assistant Professor in the Department of Internal Medicine within the Division of Allergy and Immunology at the University of South Florida Morsani College of Medicine.
- Specializes in the treatment of patients with asthma, chronic urticaria, chronic rhinitis, and other allergic diseases.
- Treats ~50 patients with moderate to severe asthma annually
- Served on ERS/ATS task forces on the management of severe asthma
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
